TrialCard News
PRESS RELEASE
TRIALCARD SELECTS BILL ENGLE AS CHIEF INFORMATION OFFICER.
Raleigh, NC June 4, 2002 - TrialCard Inc., a privately held transaction services company focused on the pharmaceutical industry, today announced that it has appointed Bill Engle as Vice President and CIO of the company.
 As CIO, Engle will be actively involved in aligning information technology with the corporate business plan, developing the infrastructure and system architecture, and communicating business rules and requirements to external/internal application developers.
Mr. Engle’s technical career began in 1970 as a computer programmer in the Steel Industry. In 1986 he joined Glaxo Wellcome as a Senior Systems Analyst and held various positions of increasing degrees of responsibilities. Most recently, Mr. Engle held the position Director of Commercial Information Management.
“Joining the TrialCard management team is a terrific opportunity. The company’s business strategy is clearly striking a chord with pharmaceutical companies and other critical medical segments. My role is to ensure a service and results oriented infrastructure that is responsive to business needs and changes in priorities.”
“Bill’s leadership and overarching vision for our data interface requirements has already made a measurable impact,” said David Cunningham, CEO of TrialCard. “His experience, insight and passion is translating into exciting, highly engineered technology solutions for our clients.”
Mr. Engle is a native of Western Pennsylvania and is an avid traveler and golfer.
###
About TrialCard:
Headquartered in Raleigh, NC, TrialCard Inc. is a transaction services company specializing in the implementation of marketing programs where drug distribution is involved, including product sampling, direct-to-consumer, direct-to-physician, loyalty programs, patient assistance programs and clinical trials companies.
TrialCard's patented “IA Technology” delivers prescription medication via magnetic stripe cards, similar to credit cards, which can be activated and de-activated. TrialCard provides pharmaceutical companies a vehicle to track and increase patient persistency and compliance.
For more information about TrialCard's services, please contact Chuck Reuben COO (call 919-845-0774, or email creuben@trialcard.com or visit www.trialcard.com.
For more information regarding this release, please contact David Chapman, CEO of 919 Marketing Company (call 919-557-7890, or email dchapman@919marketing.com).
|
|
|  | |
